Effects of drug treatments on Worm burden and enzyme levels in Schistosoma haematobium infected laboratory Animals
https://dx.doi.org/10.4314/njpar.v42i1.12
Keywords:
Guinea Pigs, Liver functioning enzymes, Worm burden, S. haematobiumAbstract
This study was carried out to evaluate the effect of drug treatments and enzymes level on the worm burden in an experimental Schistosoma haematobium infected guinea pig. Eggs of S. haematobium were collected from the urine of infected persons and hatched into miracidia. Fresh water Snail species Bulinus truncatus were exposed to miracidia and allowed for five weeks to establish infection and develop to cercaria. Guinea pigs were exposed to S. haematobium cercaraie by subcutaneous injection. The infected guinea pigs were divided into four groups, designated as 7, 28, 90 days post infection and controls. The guinea pigs were treated singly and in combination with different doses of Praziquantel (PZQ), Artemether (ART) and Artequine (ARQ). The efficacy of the different drugs on worm burden were assessed. Blood samples were collected from the guinea pigs before and after treatment for determination of Alkaline Phosphatase (ALP), Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST). Result showed that treatment with higher doses of PZQ/ART (100/200mg/kg) and PZQ/ARQ (100/200mg/kg) resulted in total worm reduction rate of 58 and a percentage efficacy of 98.3%.ARQ (300 mg/kg) had the highest percentage efficacy of 89.8% amongst the single drugs used with respect to higher doses. There were observed alteration in the levels of the enzymes after S. haematobium infection. The serum level of ALP, AST and ALT after infection generally decreased. There were various activities in the level of ALPAST and ALT after treatment with different drug regimen at different stages of S. haematobium infection.ARQ alone and in combination with PZQ had anti schistosomal effect and could be promising in controlling schistosomiasis.
References
WHO, 2020. Schistosoimsisi: Key Facts. R e t r i e v e d F r o m https://www.who.int/en/news-room/factsheets/detail/schistosomiasis
CDC, 2019. Schistosomiasis. Retrieved f r o m https://www.cdc.gov/dpdx/schistosomiasis/ index.html
Babu, S. and Nutman, T. B. 2019. Immune Responses to Helminth Infection: Carcinogenesis. Clinical Immunology (Fifth Edition). Principles and Practice. 437- 447.e1. https://doi.org/10.1016/B978-0- 7020-6896-6.00031-4
Wang, W., Wang, L., Liang, Y. S. 2012. Susceptibility or resistance of praziquantel in human schistosomiasis: a review. Parasitology Research, 111(5):1871–1877. doi: 10.1007/s00436-012-3151-z.
Vale, N., Gouveia, M. J., Rinaldi, G., Brindley, P. J., Gärtner, F., Correia da Costa, J . M . 2 0 1 7 . P r a z i q u a n t e l f o r schistosomiasis:single- drug metabolism revisited, mode of action, and resistance. Antimicrobial Agents and Chemotherapy, 6 1 : e 0 2 5 8 2 - 1 6 . doi.org/10.1128/AAC.02582-16
Silva, I. M, Thiengo, R., Conceição, M.J., Rey, L., Lenzi, H. L., Pereira F. E., & Ribeiro, P. C. (2005). Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning fromAfrica. Memórias do Instituto Oswaldo Cruz, 100(4), 445-449. https://dx.doi.org/10.1590/S0074- 02762005000400018
Silva, I. M., Pereira, F. E, Thiengo, R., Ribeiro, P. C., Conceição, M. J., Panasco, M., Lenzi, H.L. 2008. Schistosomiasis haematobia: histopathological course determined by cystoscopy in a patient in whom praziquantel treatment failed. The Revista Instituto Medicina Tropical Sao Paulo, 50:343–346. doi:10.1590/S0036- 46652008000600006.
Bang, F. B., and Hariston, N. G. 1946. Studies of Schistosomiasis japonicium IV c h e m o t h e r a p y o f e x p e r i m e n t a l Schistosomiasis japonica. America Journal of Epidemiology, 44, 348- 366
Padilla-Carlin, D., McMurray, D. N. and Hickery, A. J. 2008. The Guinea Pig as a Model of Infectious Diseases. Comparative Medicine, 58(4): 324-340
Kuntz, R. E. and Malakatis, G. M. 1955. Susceptibility studies in schistosomiasis. III. Infection of various experimental hosts with schistosoma haematobium in Egypt. Experimental Parasitology, 4: 1 – 20
Eustice, C. and Eustice, R. 2006. The facts of corticosteroids (steroids). New York, Medical Review Board. Retrieved from http://arthritis.about.com/cs/steroids/a/corti costeroids.htm
Okeke, O. C., Ubachukwu, P. O., Okafor, F. C., and Shoyinka, S.V.O. 2012. Parasitological and histopathological effects of immunosopression in guinea-pigs (Cavia procellus) experimentally infected with Schistosoma haematobium. Journal of Helminthology, 86: 387 – 390.
Shivaraj, G., Prakash, B. D., Vinayak, V. H., Avinash,A. K. Math, S. N., Venekar, Shruthi, S, K. 2009. "A review on laboratory liver function tests". The Pan African Medical Journal, 3 (17): 17
Kasper, D. L., Fauci, A, S., Hauser, Stephen L., Longo, D. L., Larry, J. J., Loscalzo, J. 2018. Harrison's principles of internal medicine (Twentieth ed.). NewYork
Lala, V., Goyal,A., Bansal, P., and Minter, D. A. Updated 2020. Liver Function Tests In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available from: https://www.ncbi.nlm.nih.gov/books/NBK4 82489/
Colley, D. G., Bustinduy, A. L., Secor, W. E. a n d K i n g , C . H . 2 0 1 4 . H u m a n Schistosomiasis. Lancet 383(9936): 2253–2264. doi: 10.1016/S0140- 6736(13)61949-2
Wu, G.Y. and Halim, M. H. 2000. Schistosomiasis: progress and problems. World Journal of Gastroenterology, 6(1): 12–19. doi: 10.3748/wjg.v6.i1.12
Tucker, M. S., Karunaratne, L. B., Lewis, F. A., Freitas T. C. and Liang Y. S. 2013. Schistosomiasis. Current Protocols in Immunology, 103, 19.1.1-19.1.58. doi. 10.1002/0471142735.im1901s103
Xiao, S., Shen, B., Chollet, J., Utzinger, J. and Tanner, M. 2001. Tegumental alterations in juvenile Schistosoma haematobium harboured in hamsters following artemether treatment. Parasitology International, 50, 175– 183. 29.
Van Nassauw, L., Toovey, S., Van, O. P. Den Bosch, J., Timmermans, J. P. and Vercruysse, J. 2008. Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice. Travel Medicine and Infectious Disease, 6, 253–258
Manneck, T., Haggenmu, Y. and Keise, J. 2010. Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni. Parasitology, 137, 85–9
Hoff. J. (2000). Methods of blood collection in mouse. LabAnim (NY) 29; 47-53
Reitman, S. and Frankel, S. 1957. A colorimetric method for determination of serum glutamic oxaloacetic and glutamic pyruvic transaminases. American Journal of Clinical Pathology, 28: 56 – 62
Babson, A. L., Greeley, S. J., Coleman, C. M., Philips, G. E. 1966. Phenolphthalein monophosphate as a substrate for serum alkaline phosphatase. Clinical Chemistry, 12(18): 482 – 490.
Kamiya, H, Ozaki, T and Inaba, T (1993). Immunizing potential of ultraviolet attenuated cercariae of Schistosoma mansoni in rodent host. Parasitology Research 79, 293-296
Tzanetou, K., Adamis, G., and Andipa, E., 2007. Urinary Tract Schistosoma haematobium Infection: A Case Report. Journal of Travel Medicine, 14(5):334-7 • DOI: 10.1111/j.1708-8305.2007.00137.x
Imbert-Eastablet, D., Vera, C., Selli, B. and Jourdane, J. (1992). The mouse as a suitable hostfor for an isolate of Schistosoma heamatobium from Niger. Journal of Helminthology, 66; 1-5
Njoroge, V. K., Nyundo, F., Limo, M. and Yole, D. S. 2007. A comparative study of multiple versus single doses of Schistosoma h a e m a t o b i u m i n g o l d e n h a m s t e r (Mesocricetus auratus). Africa Journal of Health Science, 14 187-194
Aboueldahab, M.M. and Elhussieny, E. A. 2016. Antiparasitic and physiological evaluation of Curcuma longa extract and/or PZQ on Schistosoma mansoni infected mice. International Journal of Advanced Research, 4(6); 1020-1039
Lamberton, P. H. L. Faust, C. L., and Webster, J. P. 2017. Praziquantel decreases fecundity in Schistosoma mansoni adult worms that survive treatment: evidence from a laboratory life-history trade-offs selection study. Infectious Diseases of Poverty, 6: 110 doi: 10.1186/s40249-017- 0324-0
Delgado, V. S., Sufirez, D. P., Cesari, I. M. and lncani, R. N. 1992. Experimental chemotherapy of Schistosoma mansoni with praziquantel and oxamniquine: differential effect of single or combined formulations of drugs on various strains and on both sexes of the parasite. Parasitology Research, 78: 648-654
Fallon, P. G., Sturrock, R. F., Capron, A., Niang, M., Doenhoff, M. J. 1995. Short report: diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni. American Journal of Tropicaal Medicine and Hygiene, 53:61-62
Kovac, J., Vargas, M. and Keiser, J. 2017. In vitro and in vivo activity of R- and Spraziquantel enantiomers and the main human metabolite trans-4-hydroxy praziquantel against Schistosoma haematobium. Parasites Vectors, 10: 365 https://doi.org/10.1186/s13071-017-2293-3
Wang, X., Yu, D., Li, C. Zhan, T. Zhang, T. Ma, H., Xu, J. and Xia, C. 2019. In vitro and in vivo activities of DW-3-15, a commercial praziquantel derivative, against Schistosoma japonicum. Parasites Vectors,12:199. https://doi.org/10.1186/s13071-019-3442-7
Xiao, SH, Tanner, M., Shen B., Utzinger, J. and Chollet, J. 2006. Effect ofArtemether on the Tegument of Adult Schistosoma Haematobium Recovered From Mice. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, 24(6):425-32
Xiao, S., Sun, J. & Chen, M. 2018. Pharmacological and immunological effects of praziquantel against Schistosoma japonicum: a scoping review of experimental studies. Infectious Diseases of Poverty, 7:9 https://doi.org/10.1186/s40249- 018-0391-x
Genetu Bayih, A., Debnath, A., Mitre, E., Huston, C. D., Laleu, B., Leroy, D., Blasco, B., Campo, B., Wells, T. N. C., Willis, P.A., Sjö, P., Van Voorhis, W. C., Pillai, D. R. 2017. Susceptibility testing of medically important parasites. Clinical Microbiology Reviews, 30:647– 669.https://doi.org/10.1128/CMR.0 0111-16.
Liang, Y. S., Li, H. J., Dai, J. R., Wang, W., Qu, G. L., Tao, Y. H., Xing, Y.T., Li, Y. Z., Qian, K. and Wei, J. Y. 2011. Studies on resistance of Schistosoma to praziquantel XIII resistance of Schistosoma japonicum to praziquantel is experimentally induced in laboratory. Zhongguo Xue Xi chong Bing Fang Zhi Za Zhi, 6: 605-1
Guirguis, F.R, 2003. Efficacy of praziquantel and Ro 15-5458, a 9-acridanone-hydrazone d e r i v a t i v e , a g a i n s t S c h i s t o s o m a haematobium. Arzneimittelforschung, 53: 57–61.
Keiser, J., Chollet, J., Xiao, S. H., Mei, J. Y., Jiao, P. Y., Utzinger, J. and Tanner, M. 2009. Mefloquine an aminoalcohol with promising antischsitosomal properties in mice. PLoS Neglected Tropical Diseases, 3 (1): e350. doi:10.1371/journal.pntd.0000350
Eberemu, N.C. and Okafor, F.C. 2016. Effect of treatment with different drug regimen and concentration on worm burden reduction in guinea pigs infected with Schsitosoma haematobium. Journal of Tropical Biosciences, 11: 1-16
Keiser, J., N'Guessan, N.A., Adoubryn, K.D., Silué, K.D., Vounatsou, P., and Hatz, C. 2010. Efficacy and safety of mefloquine, artesunate, mefloquine- artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial. Clinical Infectious Diseases, 50(9):1205-13.
Botros, S. S., Hammam, O. A., El- Lakkany, N. M., Seif el-Din, S. H. and Ebeid, F. A. 2008. Schistosoma haematobiumI (Egyptian strain): rate of development and effect of praziquantel treatment. Journal of Parasitology, 94(2): 386-394
Keiser, J. Maneck, T. and Vargas, M. 2011. Interactions of mefloquine with praziquantel in the Schistosoma mansoni mouse model and in vitro. Journal of Antimicrobial Chemotherapy, 66(8): 1791-1797. doi 10.1093/jac/dkr178
El-Shenawy, N. S. and Soliman, M. F. M. 2003. Evaluation of the protective effect of two antioxidative agents in mice experimentally induced with Schistosoma mansoni: biochemical and parasitological aspects. Journal of the Egyptian German Society Zoology, 40: 201-216.
Jatsa, H. Gipwe, N., Nkondo, E., Kenfack, C., Simo, D., Fassi, J….Tchuem Tchuenté, L. 2019. Efficacy of Ozoroa pulcherrima Schweinf methanolic extract against Schistosoma mansoni-induced liver injury in mice. Journal of Traditional and Complementary Medicine, 9(4): 304- 311. 10.1016/j.jtcme.2017.08.009
El-Rigal, N. S. and Hetta, M. H. 2006. Effect of Citrus reticulata on some serum protein fractions of mice after Schistosoma mansoni infection. Journal of Applied Science, 7: 1447-1455
Egoro, E. T., Ilegbedion, G. I. Udu Loveday, Z. and Shonibare, M.S. 2017. Blood biochemical and haematological alterations in Schistosoma mansoni infected patients in Ijora–Badia Nigeria. European Journal of Biomedical and Pharmaceutical Sciences, 4 (11): 148–152.
Araujo-Montoya, B. O., Rofatto, H. K., Tararam, C. A., Farias, L. P., Oliveira, K. C., Verjovski-Almeida, S. A. and Wilson, L. C. C. 2011. Schistosoma mansoni: molecular characterization of alkaline phosphatase and expression patterns across life cycle stages. Experimental arasitology, 129(3):284–91. doi:10.1016/j.exppara.2011.07.008
AEl-Banhawe, M., Ashry, M. A., ELAnsary, A. K. and Aly, S. A. 2007. Effect of Curcuma longa or parziquantel on Schistosoma mansoni infected mice liver Histological and histochemical study. Indian Journal of Experimental Biology, 45: 877- 889
Costain, A. H. MacDonald, A. S. and Smits, H. H. 2019. Schistosome Egg Migration: Mechanisms, Pathogenesis and Host Immune Responses. Frontiers Immunology, 10: 749. doi: 10.3389/fimmu.2019.00749
Schwartz, C. and Fallon, P.G. 2018. Schistosoma “Eggs-Iting” the Host: Granuloma Formation and Egg Excretion. F r o n t i e r s I m m u n o l o g y , doi.org/10.3389/fimmu.2018.02492
Dkhi, M. A. 2014. Role of berberine in ameliorating Schistosoma mansoni-induced hepatic injury in mice. Biological Research, 47. doi.org/10.1186/0717-6287-47-8
El-Lakkany, N. M., Seif el-Din, S. H., Badawy, A. A. and Ebeid, F. A. 2004. Effect of artemether alone and in combination with grapefruit juice on hepatic drugmetabolising enzymes and biochemical aspects in experimental Schistosoma mansoni. International Journal for Parasitology, 34(12):1405-1412
Ellen, E. M. (Writer), Do, S. S. (Reviewed) 2019. ALP (Alkaline Phosphatase Level) Test. Health line. Retrieved from https://www.healthline.com/health/alp
Mata-Santos, H. A., Dutra, F. F., Rocha, C. C., Lino, F. G., Xavier, F. R., Chinalia, L. A., Hossy, B. H., Castelo- Branco, M. T. L., Teodoro, A. J., Paiva, C. N., Pyrrho, A. S. 2014. Silymarin Reduces Profibrogenic Cytokines and Reverses Hepatic Fibrosis in Chronic Murine Schistosomiasis. Antimicrobial Agents and Chemotherapy, 58(4):2076–2083.
Shaker, S., Samy, N., and Ashour, E. 2014. Hepatobiliary Schistosomiasis. Journal of Clinical Translational Hepatology, 2(3): 212–216. doi: 10.14218/JCTH.2014.00018
Malakouti, M. Kataria, A., Ali, S. K and Schenkar, S. 2017. Elevated liver enzymes in asymptomatic patients-What should I do? Journal of Clinical Translational Hepatology, 5(4) 394-403
Nationwide Children, 2020. Potential implication of elevated liver enzymes. R e t r i e v e d f r o m https:/www.nationwidechildrens.org
E l - Z a y a d i , A . ( 2 0 0 4 ) C u r s e o f schistosomiasis on Egyptian liver. World Journal Gastroenterology, 10(8): 1079- 1081
Cavalcanti, M. G., de Araujo-Neto, J. M., Peralta, J. M. 2015. Schistosomiasis: Clinical Management of Liver Disease. C l i n i c a l L i v e r D i s e a s e , 6 ( 3 ) . https://doi.org/10.1002/cld.495
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Nigerian Journal of Parasitology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
